This is a competing continuation application for the Michigan Alzheimer's Disease Research Center (MADRC). Since it was established in September of 1989, the MADRC has supported highly productive research projects in neurodegenerative diseases and integrated and coordinated research in Alzheimer's disease and related disorders at the University of Michigan and throughout the State of Michigan, fostering new research endeavors and attracting the interest and efforts of others in this field. The MADRC has come to play a central role in the expanding commitment of the University to issues of aging and dementia. Building upon the internationally recognized strengths of the University in the neurological, medical and social sciences, the MADRC has developed an environment that has enhanced the quality and productivity of research, generated interdisciplinary discussion and collaboration, and attracted others to join the efforts to combat neurodegenerative diseases. The MADRC has also become a regional, state and national resource for collaborative efforts to improve our understanding and treatment of Alzheimer's disease and related disorders. This application reflects the significant strides made by the MADRC. We propose to increase the number of research projects from three to six, incorporating several of the most promising projects from a much larger collection of investigations underway at the University of Michigan. These projects span the full range of inquiry needed to address neurodegenerative diseases, including clinical studies of affected persons (Projects 1 and 2), postmortem studies of neurodegenerative diseases associated with cognitive and movement disorders (Projects 2 and 4), animal models for study of pathophysiology and treatment (Project 5) and assessment of the public knowledge of and attitudes toward dementia and awareness and utilization of services for dementia in the state (Project 6). These and many other currently funded and developing projects will continue to utilize the resources provided by four established and two newly developed Cores of the MADRC. The Administrative Core integrates and coordinates the entire MADRC, critically reviews scientific projects, funds pilot projects, and manages resources; the Clinical Core identifies, characterizes and classifies patients with neurodegenerative diseases, gives clinical consultation for investigators and brings the resources of the MADRC to underserved persons in rural and urban sites; the Neuropathology Core provides postmortem diagnosis and tissue for research; the Education and Information Transfer Core generates innovative outreach and training efforts, drawing upon the Michigan Dementia Program; the Neuropsychology Core provides neuropsychological evaluation and consultation; and the Biostatistics Core supplies biostatistical consultation and central data management. Under vigorous new leadership, the MADRC plans to continue its productive and collaborative research and service activities.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG008671-07
Application #
2050323
Study Section
Special Emphasis Panel (ZAG1-MBM-5 (01))
Project Start
1989-09-29
Project End
1999-05-31
Budget Start
1995-06-01
Budget End
1996-05-31
Support Year
7
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Neurology
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384
Michaud, Tzeyu L; High, Robin; Charlton, Mary E et al. (2017) Dependence Stage and Pharmacoeconomic Outcomes in Patients With Alzheimer Disease. Alzheimer Dis Assoc Disord 31:209-217
Monin, Joan K; Poulin, Michael J; Brown, Stephanie L et al. (2017) Spouses' daily feelings of appreciation and self-reported well-being. Health Psychol 36:1135-1139
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Cary, Brian P; Brooks, Allen F; Fawaz, Maria V et al. (2016) Synthesis and Evaluation of [(18)F]RAGER: A First Generation Small-Molecule PET Radioligand Targeting the Receptor for Advanced Glycation Endproducts. ACS Chem Neurosci 7:391-8
Karch, Celeste M; Ezerskiy, Lubov A; Bertelsen, Sarah et al. (2016) Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One 11:e0148717
Mez, Jesse; Mukherjee, Shubhabrata; Thornton, Timothy et al. (2016) The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable. Neurobiol Aging 41:115-121
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150
Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17

Showing the most recent 10 out of 274 publications